Related Experiment Video
Updated: Jun 15, 2025
05:28
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
3.4K
Integrated analysis reveals NLRC4 as a potential biomarker in sepsis pathogenesis
Chunhui Jiang1,2,3, Jiani Chen1,2,3, Jiaqing Xu2,3
1School of Basic Medical Sciences & Forensic Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China.
Genes and Immunity
|August 24, 2024
Summary
This study identifies NLRC4 as a key immune gene in sepsis, showing its increased expression in blood cells. This finding offers potential for improved sepsis diagnosis and treatment strategies.
Area of Science:
- Immunology
- Molecular Biology
- Genomics
Background:
- Sepsis is a major cause of mortality with incompletely understood immune responses.
- Identifying molecular mechanisms is crucial for effective sepsis management.
Purpose of the Study:
- To elucidate molecular mechanisms of the immune response in sepsis.
- To identify potential diagnostic and therapeutic targets for sepsis.
Main Methods:
- Bulk and single-cell RNA sequencing (scRNA-seq).
- Gene Ontology (GO) enrichment analysis.
- Weighted Gene Co-Expression Network Analysis (WGCNA).
- Protein-protein interaction (PPI) analysis.
- Enzyme-linked immunosorbent assay (ELISA).
- pySCENIC for transcription factor identification.
Main Results:
- Significant enrichment of immune-related genes in sepsis.
- NLRC4 identified as a highly expressed hub gene in sepsis, validated by ELISA.
- scRNA-seq revealed increased NLRC4 expression in monocytes and neutrophils during sepsis.
- Upstream transcription factors regulating NLRC4 were identified.
Conclusions:
- NLRC4 is a promising biomarker for sepsis diagnosis.
- Targeting NLRC4 may offer new therapeutic avenues for sepsis treatment.
